The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AMLX FINANCIAL STATEMENTS

Amylyx Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

AMLXAmylyx Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M400 M2020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-20.1 M $ · -Infinity%Operating Income-162.1 M $ · -Infinity%Pre-tax Income-152 M $ · -Infinity%Net Income to Owners-152.1 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-20.1 M $—
Operating Income-162.1 M $—
EBITDA-149.8 M $—
Net Income to Owners-152.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M2020202120222023202420252026

Capital Structure

Q2 2026
Total Assets264.6 M
  • Equity239.2 M $90%
  • Current Liabilities21.2 M $8%
  • Long-term Liabilities4.2 M $2%

Key Figures

YoY change
Total Assets264.6 M $+36.0%
Total Liabilities25.4 M $-5.0%
Total Equity239.2 M $+42.5%
Cash & ST Investments250.8 M $+38.7%
Total Debt5.3 M $-11.9%
Net Debt-44.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M02020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-126.6 M $Operating-78.8 M $Investing196.1 M $Financing-9.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-126.6 M $—
Capital Expenditures140 K $+109.0%
Free Cash Flow-126.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AMLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.